Kennedy Capital Management »

Halozyme Therapeutics shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 663k 36.96
2023-09-30 $25M 647k 38.20
2023-06-30 $22M 618k 36.07
2023-03-31 $19M 504k 38.19
2022-12-31 $33M 574k 56.90
2022-09-30 $26M 646k 39.54
2022-06-30 $27M 602k 44.00
2022-03-31 $22M 562k 39.88
2021-12-31 $22M 540k 40.21
2021-09-30 $22M 549k 40.68
2021-06-30 $16M 353k 45.41
2021-03-31 $15M 356k 41.69
2020-12-31 $14M 333k 42.71
2020-09-30 $8.8M 334k 26.28
2020-06-30 $9.0M 337k 26.81
2020-03-31 $6.2M 344k 17.99
2019-12-31 $4.1M 128k 31.94
2019-09-30 $2.6M 167k 15.51
2019-06-30 $3.1M 178k 17.18
2019-03-31 $2.9M 178k 16.10
2018-12-31 $3.5M 236k 14.63
2018-09-30 $11M 595k 18.17
2018-06-30 $10M 608k 16.87
2018-03-31 $10M 515k 19.59
2017-12-31 $10M 508k 20.26
2017-09-30 $9.8M 566k 17.37
2017-06-30 $7.0M 546k 12.82
2017-03-31 $9.0M 696k 12.96
2016-12-31 $6.9M 700k 9.88
2016-09-30 $6.5M 539k 12.08
2016-06-30 $1.0M 121k 8.63
2016-03-31 $698k 74k 9.47
2015-12-31 $1.2M 71k 17.33
2015-09-30 $649k 48k 13.43
2015-06-30 $1.1M 47k 22.58